Therapeutics News and Research

RSS

FDA approves new drug to treat adults with community-acquired bacterial pneumonia

The U.S. Food and Drug Administration today approved Xenleta (lefamulin) to treat adults with community-acquired bacterial pneumonia.

19 Aug 2019

Binge drinking may cause more damage to women than men

Alcohol consumption is a major cause of chronic liver disease in the United States, and binge drinking is emerging as a significant contributor to liver injury.

19 Aug 2019

Discover the latest advances in neuromuscular therapeutics at NMD 2019

The 2nd Neuromuscular Drug Development Summit, or NMD, will be held in Boston, MA, from October 23-25,2019.

From Hanson Wade 19 Aug 2019

Northwestern scientists receive $3.1 million grant to investigate drug therapies for ALS

Two Northwestern University scientists have received a $3.1 million grant from the National Institute on Aging to collaborate and investigate drug therapies for amyotrophic lateral sclerosis.

18 Aug 2019

Advanced method to accurately detect low-level somatic mutation in intractable epilepsy

KAIST medical scientists have developed an advanced method for perfectly detecting low-level somatic mutation in patients with intractable epilepsy. Their study showed that deep sequencing replicates of major focal epilepsy genes accurately and efficiently identified low-level somatic mutations in intractable epilepsy.

16 Aug 2019

Scientists find a potent weapon against antibiotic resistance

Antibiotic resistance is a big threat to global health, and a growing number of infections are now becoming harder to treat. The usual treatments, like antibiotics used to treat them, becomes less effective. Now, a team of researchers may have found a potent weapon against antibiotic-resistant bacteria, which can help treat persistent infections.

15 Aug 2019

Powerful weapon discovered to fight antibiotic resistance in Staphylococcus aureus

Staphylococcus aureus bacteria are a major cause of serious infections that often persist despite antibiotic treatment, but scientists at the UNC School of Medicine have now discovered a way to make these bacteria much more susceptible to some common antibiotics.

14 Aug 2019

UTEP professor receives $2.7 million NIH grant to study AIDS-associated fungal meningitis

The National Institutes of Health recently awarded a $2.7 million grant to Luis R. Martinez, Ph.D., associate professor of biological sciences at The University of Texas at El Paso, to study a potentially life-threatening fungus and suggest possible treatments.

14 Aug 2019

Scientists demonstrate an in vitro kidney model

Kidneys work to constantly filter blood and remove toxins from the body. Conditions such as chronic kidney disease are characterized by a reduced ability to perform this essential function.

14 Aug 2019

Roswell Park receives more than $15 million in grants for cancer research

Roswell Park Comprehensive Cancer Center researchers have received more than a dozen recent grant awards totaling more than $15.4 million.

14 Aug 2019

Uchicago Medicine oncologist to receive 2019 Henry M. Stratton Medal for hematology research

For his pioneering hematology research, University of Chicago Medicine oncologist and professor Richard A. Larson, MD, will receive the 2019 Henry M. Stratton Medal from the American Society of Hematology.

13 Aug 2019

Tissue model of Alzheimer's mimics beta-amyloid's effects on blood-brain barrier

Beta-amyloid plaques, the protein aggregates that form in the brains of Alzheimer's patients, disrupt many brain functions and can kill neurons. They can also damage the blood-brain barrier — the normally tight border that prevents harmful molecules in the bloodstream from entering the brain.

13 Aug 2019

Engineers develop tissue model that mimics beta-amyloid's effects on blood-brain barrier

Beta-amyloid plaques, the protein aggregates that form in the brains of Alzheimer's patients, disrupt many brain functions and can kill neurons.

13 Aug 2019

Antibody may help the immune system fight sepsis-related fungal infections

An antibody that blocks the "programmed cell death" pathway may help the immune system fight off sepsis-related fungal infections, according to animal studies reported in SHOCK: Injury, Inflammation, and Sepsis: Laboratory and Clinical Approaches, Official Journal of the Shock Society.

12 Aug 2019

Longer-lived, but less toxic drug may work better for pancreatic cancer

Unlike many other cancers, most pancreatic tumors are rock hard.

9 Aug 2019

Three new early-career investigators join federally funded precision medicine initiative

Three new early-career investigators have been selected to be a part of the University of Kansas Medical Center's $11.5 million precision medicine-focused federal grant.

9 Aug 2019

Researchers test new drug to treat patients with chylomicronemia syndrome

People with familial chylomicronemia syndrome are born with a genetic mutation that means they can't produce an enzyme called lipoprotein lipase.

9 Aug 2019

Treatment with both targeted cancer therapy and MS drug halts glioblastoma stem cells

Glioblastoma is an aggressive form of brain cancer that infiltrates surrounding brain tissue, making it extremely difficult to treat with surgery.

9 Aug 2019

UMB startup releases cutting-edge software platform for pharmaceutical researchers

Pumas-AI, a new University of Maryland, Baltimore startup company established by University of Maryland School of Pharmacy faculty members Vijay Ivaturi, PhD, assistant professor, and Joga Gobburu, PhD, MBA, professor, has released its first, cutting-edge software platform for pharmaceutical researchers and clinicians.

9 Aug 2019

New way to identify inflammation occurring in eosinophil-related disorders

Diagnosing and monitoring an inflammatory gastrointestinal disease may soon become less invasive and more accurate, thanks to the pioneering research and commitment to patient health of three University of Utah physicians.

8 Aug 2019

Therapeutics News and Research

FDA approves new drug to treat adults with community-acquired bacterial pneumonia

Binge drinking may cause more damage to women than men

Discover the latest advances in neuromuscular therapeutics at NMD 2019

Northwestern scientists receive $3.1 million grant to investigate drug therapies for ALS

Advanced method to accurately detect low-level somatic mutation in intractable epilepsy

Scientists find a potent weapon against antibiotic resistance

Powerful weapon discovered to fight antibiotic resistance in Staphylococcus aureus

UTEP professor receives $2.7 million NIH grant to study AIDS-associated fungal meningitis

Scientists demonstrate an in vitro kidney model

Roswell Park receives more than $15 million in grants for cancer research

Uchicago Medicine oncologist to receive 2019 Henry M. Stratton Medal for hematology research

Tissue model of Alzheimer's mimics beta-amyloid's effects on blood-brain barrier

Engineers develop tissue model that mimics beta-amyloid's effects on blood-brain barrier

Antibody may help the immune system fight sepsis-related fungal infections

Longer-lived, but less toxic drug may work better for pancreatic cancer

Three new early-career investigators join federally funded precision medicine initiative

Researchers test new drug to treat patients with chylomicronemia syndrome

Treatment with both targeted cancer therapy and MS drug halts glioblastoma stem cells

UMB startup releases cutting-edge software platform for pharmaceutical researchers

New way to identify inflammation occurring in eosinophil-related disorders

Advancing therapeutic biopolymer development eBook

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News